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Purpose: To investigate the efficiency of lysozyme and albumin removal from silicone hydrogel and conventional contact
lenses, using a polyhexamethylene biguanide multipurpose solution (MPS) in a soaking or rubbing/soaking application
and a hydrogen peroxide system (H2O2).
Methods: Etafilcon A, lotrafilcon B and balafilcon A materials were incubated in protein solutions for up to 14 days.
Lenses were either placed in radiolabeled protein to quantify the amount deposited or in fluorescent-conjugated protein
to identify its location, using confocal laser scanning microscopy (CLSM). Lenses were either rinsed with PBS or soaked
overnight in H2O2 or MPS with and without lens rubbing.
Results: After 14 days lysozyme was highest on etafilcon A (2,200 μg) >balafilcon A (50 µg) >lotrafilcon B (9.7 µg) and
albumin was highest on balafilcon A (1.9 µg) =lotrafilcon B (1.8 µg) >etafilcon A (0.2 µg). Lysozyme removal was
greatest for balafilcon A >etafilcon A >lotrafilcon B, with etafilcon A showing the most change in protein distribution.
Albumin removal was highest from etafilcon A >balafilcon A >lotrafilcon B. H2O2 exhibited greater lysozyme removal
from etafilcon A compared to both MPS procedures (p<0.001) but performed similarly for lotrafilcon B and balafilcon A
lenses (p>0.62). Albumin removal was solely material specific, while all care regimens performed to a similar degree
(p>0.69).
Conclusions: Protein removal efficiency for the regimens evaluated depended on the lens material and protein type.
Overall, lens rubbing with MPS before soaking did not reduce the protein content on the lenses compared to nonrubbed
lenses (p=0.89).
The initial response of the immune system to isolate an
implanted  material  from  the  body  before  fibrous  or
granulomatous tissue growths is the development of a coating
consisting of a variety of proteins and lipids [1-3]. A similar
response is found after a new contact lens is placed onto the
ocular surface, with organic (proteins, mucins, and lipids) and
inorganic (calcium, potassium, and chloride ions) tear-film
elements  in  addition  to  exogenous  components,  such  as
cosmetics, forming a “coating” over the lens within minutes
of  exposure  to  the  eye  [4-10].  A  variety  of  ocular
complications during lens wear can be directly related to such
deposition, particularly on soft contact lenses [11-16]. One
particularly  relevant  complication  is  giant  papillary
conjunctivitis (GPC), which has been observed with a variety
of materials and wearing schedules [14,15,17,18]. GPC has
been closely linked with depositions of denatured proteins on
the lens surface and potentially mechanical lens interactions
with the under surface of the lids [11]. With modern lens
materials,  development  of  papillae  on  the  palpebral
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conjunctiva is among the most prominent complications that
occur during contact lens wear [19,20].
More than 100 different proteins have been identified in
the human tear film [21,22], with a total concentration of 6.5–
9.6 mg/ml [23]. This concentration may change over the day
[24],  during  sleep  [25],  and  under  specific  conditions,
including  stimulated  tearing  [26,27],  increasing  age  [28],
contact lens wear [29]], and in various eye diseases, such as
Sjögren’s syndrome [30]. Lysozyme is of particular interest
due to its high abundance and antimicrobial activity in the tear
film [26,27,31]. It has a concentration in the tear film of
1.9 mg/ml [25,27], exhibits an overall positive charge with an
isoelectric point pH of 11.1, and is constituted of 129 amino
acids, which results in a molecular weight of 14.5 kDa [32].
Albumin is the most abundant protein in blood serum and is
involved in the initial response to implanted biomaterials [2].
Albumin has 585 amino acids, a molecular weight of 66 kDa,
and its concentration in the tear-film ranges from 0.02 to
0.04 mg/ml during the day [24,26] and rises to approximately
0.5 mg/ml after sleep [25,33,34]. Its overall negative charge
(isoelectric  point  pH=4.7)  results  in  a  different  sorption
behavior  compared  to  lysozyme  [34-37].  However,  both
proteins  have  frequently  been  detected  on  ex  vivo  lenses
[38-43].
Multipurpose  care  solutions  (MPSs)  and  hydrogen
peroxide-based systems (H2O2) are the most commonly used
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79care regimens to clean and disinfect soft contact lenses [44].
Due  to  their  convenience,  MPS  systems  have  become
increasingly  popular  over  the  years  and  now  account  for
approximately 90% of the market share for care regimens,
with  H2O2  being  used  by  <10%  of  patients  [44-46].  The
majority of MPS systems were initially developed for use with
conventional  poly-2-hydroxyethylmethacrylate  (pHEMA)-
based materials and were prescribed using a manual rub and
rinse step before overnight soaking of the lenses [47,48]. To
improve convenience, several care systems were developed
that were approved as “NO-RUB” products, with a brief rinse
and long overnight soak only being required.
Silicone hydrogel (SH) contact lens materials provide
high levels of oxygen to the cornea [49,50] and result in fewer
hypoxic complications compared with conventional pHEMA-
based materials [51,52]. The majority of SH materials are
worn on a daily wear basis [53], and 90% of the patients
wearing these materials on an overnight or continuous wear
basis will remove the lenses at some point during the wearing
cycle [54]. Once removed, the lenses require cleaning and
disinfection before reinsertion.
Previous studies have reported that the deposition profile
of  SH  and  conventional  pHEMA-based  materials  differ
markedly, with SH materials depositing lower amounts of tear
proteins,  which  are  primarily  denatured.  On  hydrogel
biomaterials, denatured proteins are more tightly bound than
native proteins [2,55], which raises the question of whether
proteins bound to contact lens materials can be removed from
the lens by rinsing and/or soaking alone.
Therefore,  the  purpose  of  this  in  vitro  study  was  to
investigate the efficiency of protein removal from pHEMA-
based  and  SH  contact  lens  materials,  using  commonly
prescribed care regimens. The location and amount of two
tear-film proteins (lysozyme and albumin) was determined
before  and  after  soaking  the  lenses,  using  either  a
polyhexamethylene biguanide-based MPS in a RUB or NO-
RUB format or a NO-RUB H2O2 system.
METHODS
Two  SH  materials  (lotrafilcon  B,  balafilcon  A)  and  one
pHEMA-based lens (etafilcon A) were investigated (Table 1).
All  lenses  had  a  power  of  −3.0  diopters  (D)  and  were
presoaked in sterile phosphate buffered saline (PBS; 1.9 mM
monobasic  sodium  phosphate,  8.1  mM  dibasic  sodium
phosphate, 154 mM sodium chloride, pH 7.4) 24 h before
protein  incubation  to  remove  any  associated  packaging
components from the lens material.
Two techniques were used in this study to quantify and
locate the protein of interest on the contact lens. In Experiment
1, a radiolabeling technique was used to quantify the overall
amount  of  bound  protein  per  lens,  and  in  Experiment  2,
confocal laser scanning microscopy (CLSM) identified the
location  of  fluorescent-labeled  protein  on  the  surface  and
inside the lens matrix (bulk) (for conjugation methods, see
below). Hen egg lysozyme (HEL; Sigma-Aldrich, St. Louis,
MO) and bovine serum albumin (BSA; Sigma-Aldrich) were
investigated  in  separate  experiments,  applying  both  the
radiolabeling  and  CLSM  method.  BSA  and  HEL  were
substituted  for  human  albumin  and  lysozyme  primarily
because  of  cost  considerations;  however,  the  shape  and
physicochemical properties between the proteins are similar,
and they are expected to behave in an analogous manner
[56-67].
In both experiments lenses were incubated in amber glass
vials  filled  with  protein  solution,  with  physiological
concentrations of 1.9 mg/ml HEL [25] or 0.5 mg/ml BSA
[34].  Etafilcon  A  is  known  to  accumulate  high  levels  of
lysozyme [62,63] and was therefore incubated in 3 ml of HEL
solution to ensure sufficient protein was available over the
incubation  period  of  14  days.  All  other  lens/protein
combinations were soaked in 1 ml of solution. Three replicates
were  used  for  each  condition,  and  the  incubation  was
performed at 37 °C under constant rotation of 72 rpm for time
periods of 1 and 14 days. Figure 1 provides an overview of
the experimental procedures.
After protein incubation, lenses underwent one of four
treatments, described below. The contact lens care regimens
used in this study are listed in Table 2.
• (a) “RINSE”—all lenses were held with plastic-
tipped tweezers and gently swirled in 100 ml PBS for 3 s
TABLE 1. LIST OF CONTACT LENSES INVESTIGATED IN THIS STUDY.
Trade name USAN FDA Manufacturer Surface modification Water
content (%)
Principal monomers
ACUVUE® 2™ Etafilcon A IV Johnson & Johnson,
Jacksonville, FL
none 58 HEMA, MAA
AIR OPTIX™
AQUA
Lotrafilcon B I CIBA Vision, Duluth,
GA
25 nm high refractive index
coating
33 DMA, TRIS, siloxane
macromer
PureVision® Balafilcon A III Bausch & Lomb,
Rochester, NY
Plasma oxidation (glassy
islands)
36 NVP, TPVC, NVA, PBVC
DMA N,N-dimethylacrylamide; HEMA 2-hydroxyethyl methacrylate; MAA methacrylic acid; NVA N-vinyl aminobutyric acid;
NVP N-vinyl pyrrolidone; PBVC poly[dimethylsiloxyl] di [silylbutanol] bis[vinyl carbamate]; TPVC tris-(trimethylsiloxysilyl)
propylvinyl carbamate; TRIS trimethyl siloxy silane.
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80(repeated twice) and either processed immediately for
protein localization or quantification or further prepared
for  overnight  soaking  using  one  of  three  differing
treatments (b, c, or d).
•  (b)  “MPS-NO-RUB”—lenses  were  individually
placed in COMPLETE® Easy Rub contact lens cases
(Advanced Medical Optics, Santa Ana, CA), which were
filled with 3 ml of COMPLETE® Easy Rub solution.
• (c) “MPS-RUB”—lenses were placed in a nitrile-
gloved hand and 200 µl of COMPLETE® Easy Rub was
added; using the index finger alone, five circular rotations
on each side of the lens were performed (10 s total). The
lenses were then briefly immersed in PBS before being
placed in 3 ml of COMPLETE® Easy Rub solution.
• (d) “H2O2”—lenses were individually placed in
ClearCare®  lens  cases  (CIBA  Vision,  Duluth,  GA),
which were then filled with 9 ml of ClearCare® solution.
Lenses processed in treatments b, c, and d remained in
the respective care solution overnight for 12 h, followed by
immersing  and  swirling  for  3  s  in  fresh  PBS  and  further
processing for protein localization or quantification (Figure
1).
Three replicates for each of the three lens types (etafilcon
A, lotrafilcon B, and balafilcon A) were incubated in two
proteins (HEL and BSA) at two time points (D1, D14), using
four  cleaning  procedures  (RINSE,  MPS-NO-RUB,  MPS-
RUB, and H2O2) and two techniques to either quantify or
locate the protein on the lens. This resulted in 288 lenses being
examined.
Experiment  1:  Protein  quantification  using  I125:  In
separate experiments, HEL and BSA were conjugated to I125
using  the  iodine  monochloride  method,  as  previously
described [64,65]. Lenses were incubated in single protein
solutions containing 1.9 mg/ml HEL or 0.5 mg/ml BSA, using
a mixture of 2% labeled and 98% unlabeled protein (pH 7.4).
Following the four treatments a, b, c, or d, the remaining
Figure  1.  Schematic  diagram  for
experimental  procedures.  Contact
lenses  were  incubated  in  lysozyme
(HEL)  and  albumin  (BSA)  solution,
followed  by  overnight  soaking  in
different  care  regimens  and  the  two
methods  to  locate  and  quantify  the
protein on the lens. In the figure, 125I
indicates  iodine125;  BSA  indicates
bovine  serum  albumin;  CL  indicates
contact lens; CLSM designates confocal
laser  scanning  microscope;  Exp
indicates  Experiment;  H2O2  indicates
hydrogen peroxide; HEL designates hen
egg  lysozyme;  LY  designates  lucifer
yellow vinyl sulfone; and MPS indicates
multipurpose solution.
TABLE 2. LIST OF CARE REGIMENS USED IN THIS STUDY.
Trade name Manufacturer Disinfectant Other constituents Buffer
ClearCare® CIBA Vision, Duluth,
GA
3% hydrogen peroxide Pluronic 17R4 Phosphate
COMPLETE® MPS
Easy Rub™
Abbot Medical Optics,
Santa Ana, CA
Polyhexamethylene
biguanide (0.0001%)
Poloxamer 237, Edetate
disodium, Sodium chloride,
Potassium chloride
Phosphate
Molecular Vision 2010; 16:79-92 <http://www.molvis.org/molvis/v16/a10> © 2010 Molecular Vision
81protein  content  on  the  lens  was  determined  by  using  an
automated  gamma  counter  (1470  Wallac  Wizard;
PerkinElmer, Woodbridge, ON). For quantification purposes,
the radioactivity on each lens was converted into micrograms
of protein [66,67].
Experiment 2: Protein conjugation for confocal laser
scanning  microscopy:  In  separate  labeling  procedures,
180 mg HEL and BSA were dissolved in 0.05 M borate buffer
(pH 8.5) and 0.04 M NaCl (HEL 5 mg/ml; BSA 10 mg/ml).
The  water  soluble  fluorescent  dye  Lucifer  Yellow  VS
dilithium salt (LY; Sigma Aldrich) was dissolved in 1 ml of
borate buffer (pH 8.5; 7 mg for BSA, 10 mg for HEL). The
dye was added to the protein solution followed by gentle
stirring for 1 h in the dark. Free LY was separated from the
conjugated  proteins  using  Sephadex  G25  PD10  desalting
columns  (Amersham  Biosciences,  Piscataway,  NJ).
Following this, dialysis against PBS, using a 7-kDa molecular
weight  cutoff  dialysis  cassette,  was  performed  until  only
negligible  amounts  of  free  LY  were  detected  with  a
fluorescence  spectrophotometer  (F-4500;  Hitachi,  Tokyo,
Japan). The labeling efficiency was calculated by determining
the protein concentration in the solution, using the DC Protein
Assay  (Bio-Rad,  Hercules,  CA)  and  measuring  the
absorbance at 415 nm (which is the maximum absorbance for
LY). The resulting degree of labeling was 0.26 for HEL and
2.94 for BSA (degree of labeling is the molecules of dye per
molecule of protein).
Contact lens incubation in fluorescent-labeled protein:
The conjugated protein solutions were sterilized with 0.2 μm
syringe filters (Pall Corporation, Ann Arbor, MI) to prevent
microbial contamination of the samples during the incubation
phase. Because lower amounts of labeled protein result in less
photobleaching during subsequent laser scans and to allow
consistent  settings  on  the  microscope  throughout  the
experiment, the lowest possible ratio of conjugated HEL to
unconjugated HEL was used. Contact lens materials that were
known  from  previous  studies  [66,68]  to  accumulate  large
amounts of lysozyme were incubated with 2% labeled and
98%  unlabeled  HEL,  while  other  materials  known  to
accumulate only small amounts of protein were incubated in
100%  labeled  HEL.  The  final  concentration  of  HEL  was
1.9 mg/ml (pH 7.4). Because of the lower BSA sorption rate
to contact lens materials [62], all lens types were incubated in
100% conjugated BSA.
Confocal  laser  scanning  microscopy  examination
technique: The center 4 mm of the lens was cut out using a
mechanical punch press, and the sample was gently dabbed
dry  on  lens  paper  before  it  was  mounted  onto  a  glass
microscope slide. Approximately 40 μl of PBS was used as
the mounting media. A glass coverslip was then carefully
applied and sealed with nail polish to prevent evaporation and
to stabilize the coverslip for use with the immersion objectives
of the microscope.
The  lens  materials  were  subsequently  examined  for
protein uptake by using CLSM (Zeiss Inc., Toronto, Canada).
The Zeiss 510, configuration Meta 18, was equipped with an
inverted motorized microscope Axiovert 200M. Each lens
was scanned at four random locations by using an excitation
wavelength of 405 nm (Laser Diode) and a long pass emission
filter >505 nm. Each section of z stacks was set at 1-μm
intervals, with image sizes of 512x512 pixels (230x230 µm).
Lenses  were  scanned  with  a  40×  water  immersion  C-
Apochromat objective. Using the software provided with the
microscope and ImageJ (U. S. National Institutes of Health,
Bethesda, MD), the means of the fluorescence intensity were
plotted as a function of the scanning depth. In preliminary tests
optimized  settings  for  laser  intensity,  detector  gain,  and
amplifier offset were determined using new lenses as controls
that were presoaked in PBS. This was necessary to reduce the
impact of background noise from the various lens materials.
These CLSM scan settings remained unchanged throughout
the entire experiment.
For statistical analysis of the quantitative protein uptake
and protein location, repeated measures analysis of variance
(ANOVA) was applied, followed by post hoc comparisons
using Tukey's honestly significant difference test. A p<0.05
was considered significant. To determine the significance of
differences  between  the  amount  of  protein  sorbed  to  the
investigated materials, a comparison between the RINSE data
was  tested  using  the  factors  “Protein”  (HEL  and  BSA),
“Material” (etafilcon A, lotrafilcon B, and balafilcon A), and
“Time” (D1 and D14). The cleaning efficiency was analyzed
individually for each lens–protein combination because of the
wide  range  of  protein  uptake  between  lens  materials.
Differences between the amounts of protein were determined
separately for each lens material (etafilcon A, lotrafilcon B,
and balafilcon A) with the two factors “Time” (D1 and D14)
and “Treatment” (RINSE, MPS-NO-RUB, MPS-RUB, and
H2O2), including interactions.
To determine differences in protein location, each CLSM
lens scan was sectioned into front and back surface and “bulk”
regions,  as  previously  described  [69].  Briefly,  the
fluorescence  intensity  on  the  front  and  back  surface  was
calculated by averaging the five micron scan steps around the
front and back “surface peak” and the “bulk” intensity was
calculated by averaging the innermost 30 µm of the lens scan
[69].  As  noted  in  our  previous  study  [69],  the  relative
fluorescence signal on the back surface typically showed a
minor decrease compared to the front surface. This is due to
increased absorbance of the laser light when measuring deeper
into the lens material and could be seen in the majority of
cases. Therefore, comparisons between protein location on
and within the lens focused only on differences in the front
surface versus the bulk (central) region, with the assumption
that both surfaces accumulated similar amounts of protein.
The scaling of the CLSM results was based on arbitrary units
and solely allowed comparisons between a single protein type
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82on one specific material. Using repeated measures ANOVA,
significant  differences  in  fluorescence  intensity  were
determined separately for each lens material (etafilcon A,
lotrafilcon B, and balafilcon A), with the three main effects
“Time” (D1 and D14), “Treatment” (RINSE, MPS-NO-RUB,
MPS-RUB, and H2O2), and “Location” (front surface, back
surface, and bulk), including interactions. The fluorescence
signal did not provide quantitative results and the units cannot
be  compared  directly  between  materials,  therefore
radiolabeled protein was used for quantitative comparisons.
RESULTS
Etafilcon A, lotrafilcon B, and balafilcon A incubated in I125-
labeled protein showed significantly more HEL on all lens
types  compared  to  BSA  at  all  time  points  (p<0.001).  An
increase in HEL and BSA sorption was found on all three lens
materials over time (p<0.05), except for BSA in combination
with etafilcon A (p=0.48).
Following incubation of the three contact lens materials
in either 1.9 mg/ml HEL or 0.5 mg/ml BSA, the total amount
and location of protein on these materials was determined
before and after overnight soaking in MPS with and without
manual lens rubbing (MPS-RUB, MPS-NO-RUB) or H2O2.
Etafilcon A accumulated the highest amounts of HEL
(mean 2,200 µg/lens) and the lowest amounts of BSA (mean
0.2 µg/lens) compared to the other materials (p<0.001) (Table
3).  After  overnight  soaking,  both  care  regimens  removed
significant  amounts  of  both  proteins  from  this  lens  type
(p<0.001). After 14 days of incubation, H2O2 removed 24.3%
of the HEL from etafilcon A, which was significantly more
(p<0.001) compared to MPS-RUB (15.8%) and MPS-NO-
RUB (16.3%), which were not significantly different to each
other (p=0.88). The low amounts of BSA were significantly
reduced (p<0.001) by 62.4%, 62.2%, and 55.5% by using
H2O2, MPS-RUB, and MPS-NO-RUB, respectively, with all
cleaning procedures performing similarly (p>0.98; Table 3).
The CLSM results for the different cleaning treatments
show the distribution of the fluorescent-conjugated protein on
the front surface, within the central lens bulk, and at the back
surface of etafilcon A (Figure 2A–D). Following the RINSE
procedure  alone,  HEL  sorption  to  etafilcon  A  showed  a
slightly higher protein density on the surface compared to the
bulk region on D1 (p<0.001), but this leveled out over time,
with no difference being seen on D14 (p=1.0). For both time
points, soaking in H2O2 removed significantly higher amounts
of HEL from the surface of etafilcon A compared to all the
other procedures (p<0.001), and significantly more HEL was
measured in the central region than on the surface (p<0.001).
This  phenomenon  was  seen  to  this  extent  only  with  this
specific lens protein care regimen combination. For the MPS
on  D1,  both  techniques  removed  significant  amounts  of
protein from both the surface and bulk regions compared with
RINSE alone (p<0.001). No differences between the surface
and bulk regions were measured for either RUB or NO-RUB
methods, but there was a reduction in both regions on D1 when
the lens was rubbed (p<0.001). Both techniques, RUB and
NO-RUB, removed more HEL from the surface than from the
bulk region on D14, but there was no significant difference
between the two techniques (p=0.64).
The overall BSA sorption to etafilcon A with the RINSE
procedure was similar at both time points (p=1.00), showing
an almost even distribution of the protein at the surface and in
the bulk region, as seen in Figure 2C,D. The use of MPS and
H2O2 showed a successful removal of BSA from both the
surface and the bulk regions (p<0.001), with a slightly reduced
efficiency  on  D14.  There  were  no  significant  differences
between the three procedures for either time points (p>0.95).
Lotrafilcon  B  accumulated  higher  quantities  of  HEL
(mean 9.65 µg/lens) compared to BSA (mean 1.82 µg/lens)
after 14 days of incubation in radiolabeled protein solution
(p<0.001; Table 4). Following overnight soaking none of the
care regimens removed appreciable amounts of HEL from this
lens type (p>0.46), while a small but statistically significant
reduction was seen for BSA when exposed to H2O2 (p<0.049).
After 14 days of incubation, H2O2 removed 7.2% HEL from
lotrafilcon B, which was similar to both MPS-RUB (3.6%)
and MPS-NO-RUB (2.9%) (p>0.90). The amount of BSA
removed was slightly more (14.0%, 11.9%, and 11.0%) using
H2O2, MPS-RUB, and MPS-NO-RUB, respectively, with all
cleaning procedures performing similarly (p>0.89; Table 4).
The  location  of  fluorescent-conjugated  HEL  on  the
surface and within the bulk region of lotrafilcon B is shown
in Figure 3A,B. Significantly higher amounts of HEL were
detectable on the surface of lotrafilcon B following the RINSE
procedure compared to the bulk region on D1, which became
even more distinct on D14 (p<0.001). Overnight soaking in
H2O2 or MPS with or without rubbing removed protein solely
from the central lens region on D1 (p<0.04); however, the
front surface on D1 and both locations on D14 did not show
a significant decrease in protein accumulation using any of the
three procedures (p>0.3), with the exception of the surface on
D14 after soaking in H2O2 (p=0.03).
BSA sorption to lotrafilcon B showed a trend similar to
HEL, with more BSA detected on the surface compared to the
bulk region after the RINSE procedure, as seen in Figure 3C,D
(p<0.001). All cleaning techniques removed BSA from the
central location at both time points (p<0.001). For the surface,
only MPS-RUB removed significant amounts of BSA on D1
and only MPS-NO-RUB reduced the BSA content on D14
(p<0.001). On D14, both MPS applications removed more
protein from the surface compared to the H2O2 care solution
(p<0.01), but no differences could be detected for the bulk
region (p>0.05). Although MPS-RUB removed more BSA
from the surface on D1 compared to the NO-RUB technique,
all other locations were not different on either time points for
the two MPS procedures (p>0.35).
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83Balafilcon A accumulated much higher amounts of HEL
(mean 50.0 µg/lens) compared to BSA (mean 1.90 µg/lens)
after  14  days  of  incubation  in  I125-conjugated  protein
(p<0.001;  Table  5).  After  overnight  soaking  both  care
regimens removed significant amounts of both proteins from
this lens type (p<0.01). After 14 days of incubation, HEL was
more efficiently removed from balafilcon A compared to the
other two lens materials, with similar proportions of 59.9%,
58.4%, and 61.4% for H2O2, MPS-RUB, and MPS-NO-RUB,
respectively  (p<0.001).  For  BSA,  H2O2  removed  31.7%,
which was similar to MPS-RUB (30.7%) and MPS-NO-RUB
(29.2%).  The  three  cleaning  procedures  showed  overall
Figure  2.  Lysozyme  and  albumin
distribution through etafilcon A. CLSM
(confocal  laser  scanning  microscopy)
scans  were  analyzed  to  locate  the
fluorescent-conjugated  protein  on  the
front surface, within the bulk region, and
on the back surface of etafilcon A after
one and 14 days of incubation. Lenses
were either rinsed in phosphate buffered
saline  (PBS),  soaked  overnight  in
hydrogen  peroxide  (H2O2)  or  soaked
overnight  in  a  multipurpose  solution
(MPS)  with  (MPS-RUB)  or  without
(MPS-NO-RUB) manual lens rubbing.
A, B: These panels show the results for
HEL (hen egg lysozyme), C, D: These
panels show the results for BSA (bovine
serum albumin).
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TABLE 3. TOTAL AMOUNT OF HEN EGG LYSOZYME AND BOVINE SERUM ALBUMIN SORBED TO ETAFILCON A AFTER 1 AND 14 DAYS OF
        INCUBATION, FOLLOWED BY THE TREATMENTS RINSE, MPS-NO-RUB, MPS-RUB OR H2O2 (MEAN±95% CONFIDENCE INTERVAL).
HEL BSA
ETAFILCON A D1 D14
Difference
between
treatments*
D1 D14
Difference
between
treatments*
RINSE (a) 1139.8±7.14 2200.3±15.64 (b), (c), (d) 0.16±0.037 0.20±0.037 (b), (c), (d)
MPS-NO-RUB (b) 909.3±5.52 1852.1±19.16 (a), (c), (d) 0.03±0.006 0.09±0.005 (a)
MPS-RUB (c) 906.6±13.00 1841.5±10.38 (a), (b) 0.02±0.004 0.08±0.013 (a)
H2O2 (d) 783.4±11.13 1666.1±15.83 (a), (b) 0.02±0.004 0.08±0.041 (a)
*Overall differences between treatments (p<0.05), using the combined time points.NO-RUB  removing  more  BSA  compared  to  MPS-RUB
(p<0.05).
DISCUSSION
Current soft contact lens care regimens have been evaluated
for  their  efficiency  against  both  microbial  and  tear-film
deposition on various soft lens materials [48,70-77]. Both ex
vivo and in vitro studies have demonstrated material-specific
sorption profiles and have confirmed differences between care
regimens for removing non-pathogenic (e.g., lipids, proteins)
[48,70,74-77] and microbial (e.g., bacteria, fungi) [70-73]
components from the lens. Furthermore, manual lens rubbing
reduces  the  appearance  of  visual  deposition  by  removing
general tear-film components and cosmetics from the lens
more effectively compared with soaking alone [78,79]. A
clinical study conducted by Nichols [78] determined visual
deposition  on  patient-worn  SH  lenses  after  using  various
MPSs in a rub and no-rub application. The subjective grading
method demonstrated an overall reduction in lens “haze” for
manually  rubbed  lenses  that  were  cleaned  using  either
COMPLETE® MoisturePLUS or Alcon Opti-Free Express.
Cho et al. [79] reported similar results from an in vitro study
investigating ionic high-water pHEMA-based lens materials
that were artificially deposited with albumin, hand cream, and
mascara.  Lenses  that  were  not  rubbed  before  the  soaking
process showed similar levels of deposition regardless of the
rinsing  duration.  In  contrast,  all  four  MPS  systems
investigated  removed  significant  amounts  following
extensive lens rubbing [79].
While  both  of  the  above  studies  clearly  describe
differences between care regimens and their method of use, it
still remains unclear if the deposited species were removed
primarily from the lens surface or also from the central or bulk
lens region. Of particular interest to us was the impact of care
regimens and rubbing on the removal of tear-film proteins and
whether such proteins are removed differentially from the
surface or bulk locations. Therefore, the purpose of this study
was to determine the efficiency of various contact lens care
regimens on the removal of two typical tear-film proteins,
lysozyme (HEL) and albumin (BSA), which differ markedly
in size, charge, and concentration.
As  shown  in  previous  studies  [67,69],  the  protein
distribution profile for BSA and HEL differs significantly
between lens materials. The pHEMA material etafilcon A
(Food and Drug Administration [FDA] group IV) allowed
both proteins to penetrate the lens matrix, while the high
refractive index coating and/or the properties of the lotrafilcon
B SH bulk material [80] (FDA group I) minimized protein
penetration into the material, with both proteins primarily
being  deposited  on  the  surface  region  [67,69].  It  may  be
assumed that protein sorbed onto the lens surface would be
easier to remove than protein penetrating the lens matrix.
However, results from the current study showed no change in
the overall HEL amount (by radiolabeling) and distribution
profile (by CLSM imaging) on the lotrafilcon B material after
overnight  soaking  using  a  RUB  or  NO-RUB  application
(Table  4  and  Figure  3A,B).  BSA  amounts  were  slightly
reduced (by 11–14%) for this material by either lens rubbing
or  using  H2O2  systems  (Table  4),  and  the  CLSM  results
confirmed that BSA was removed primarily from the bulk
region and not from the surface region (Figure 3C,D).
Etafilcon A allowed both BSA and HEL to fully penetrate
the  lens  bulk  region  over  time  [67,69],  and  our  study
demonstrated  that  using  either  MPS  or  H2O2  removed
significant  amounts  of  lysozyme  (15.8–24.3%)  and  BSA
(55.5–62.4%) from both the lens surface and bulk regions
(Table 3 and Figure 2A-D). When examining the differences
between  these  regimens,  it  is  clear  that  H2O2  removed
substantially more HEL from the surface region of etafilcon
A than either MPS method (Table 3 and Figure 2A,B). This
phenomenon was not observed with BSA, which deposited
substantially less than HEL (Table 3). The high levels of
deposition of the positively charged HEL on ionically charged
materials, such as etafilcon A, has been shown previously
[37,66,81].
Our results suggest that both proteins were less tightly
bound when sorbing to the surface of etafilcon A (Figure 2A-
D) compared to the lotrafilcon B material (Figures 3A-D),
which  showed  no  (or  minimal)  protein  removal  from  the
surface  following  any  of  the  cleaning  procedures.  These
findings were also confirmed in the quantitative results, which
showed a higher percentage of protein removal for etafilcon
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similar protein removal efficiencies for both BSA and HEL
(p>0.69; Table 5).
Imaging  results  of  the  fluorescent-conjugated  protein
indicated  a  higher  HEL  density  inside  the  bulk  region
compared to the surface of balafilcon A following the RINSE
procedure at both time points (p<0.001; Figure 4A,B). All
three cleaning techniques removed significant amounts of
HEL  from  both  the  surface  and  bulk  region  (p<0.001).
Soaking in H2O2 removed more HEL from the surface of
balafilcon  A  on  D1  compared  to  the  MPS  applications
(p<0.02);  however,  on  D14  all  care  regimens  performed
similarly for both surface and bulk regions (p>0.09).
BSA  showed  an  equal  distribution  throughout  the
balafilcon A material at both time points following the RINSE
procedure (p=1.0), as shown in Figure 4C,D. All cleaning
procedures removed significant amounts of BSA from the
surface and the bulk material (p<0.001). At both time points
a  higher  protein  reduction  was  seen  when  using  H2O
2
compared to both MPS applications (p<0.001), which were
not different to each other on D1 (p=1.0). Small but significant
differences could be seen on the lens surface and within the
bulk region between both MPS procedures on D14, with MPS-A compared to lotrafilcon B (Figure 2A,B) This may be due
to the conformational state of the proteins, which were sorbed
to the more hydrophilic surface (etafilcon A) compared to the
more hydrophobic surface (lotrafilcon B) typically exhibited
by  SH  materials  [82].  Previous  studies  have  determined
changes in the secondary structure for HEL and BSA when
depositing  on  contact  lenses  and  have  shown  a  higher
denaturation  rate  for  proteins  sorbed  to  SH  materials
compared  to  pHEMA  materials  [62,63,68,75,83].
Furthermore, denatured proteins typically bind more tightly
Figure  3.  Lysozyme  and  albumin
distribution  through  lotrafilcon  B.
CLSM  (confocal  laser  scanning
microscopy)  scans  were  analyzed  to
locate  the  fluorescent-conjugated
protein on the front surface, within the
bulk region, and on the back surface of
lotrafilcon B after one and 14 days of
incubation. Lenses were either rinsed in
phosphate  buffered  saline  (PBS),
soaked overnight in hydrogen peroxide
(H2O2)  or  soaked  overnight  in  a
multipurpose  solution  (MPS)  with
(MPS-RUB)  or  without  (MPS-NO-
RUB) manual lens rubbing. A, B: These
panels show the results for HEL (hen
egg lysozyme), C, D: These panels show
the  results  for  BSA  (bovine  serum
albumin).
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HEL BSA
LOTRAFILCON B D1 D14
Difference
between
treatments*
D1 D14
Difference
between
treatments*
RINSE (a) 5.14±0.64 9.65±1.54 - 0.84±0.10 1.82±0.19 (d)
MPS-NO-RUB (b) 3.28±0.85 9.37±1.72 - 0.54±0.07 1.62±0.08 -
MPS-RUB (c) 3.98±0.43 9.31±2.09 - 0.46±0.19 1.60±0.25 -
H2O2 (d) 4.41±0.84 8.96±1.28 - 0.45±0.05 1.57±0.13 (a)
*Overall differences between treatments (p<0.05), using the combined time points.
TABLE 4. TOTAL AMOUNT OF HEN EGG LYSOZYME AND BOVINE SERUM ALBUMIN SORBED TO LOTRAFILCON B AFTER 1 AND 14 DAYS OF
           INCUBATION, FOLLOWED BY THE TREATMENTS RINSE, MPS-N0-RUB, MPS-RUB, OR H2O2 (MEAN± 95% CONFIDENCE INTERVAL).material, with 58.4–61.4% removal after overnight soaking
using  any  of  the  three  treatments  (Table  5),  which  was
similarly reflected by the CLSM imaging data showing an
equal reduction throughout the balafilcon A material (Figure
4A,B). The results for BSA show removal efficiencies of
29.2–31.7%, and although the results were slightly higher for
H2O2,  significant  differences  were  only  seen  with  the
fluorescence imaging technique (Figure 3C,D).
The amount of protein removal from the lens materials
investigated  in  this  study  can  be  compared  to  previous
findings  from  both  Franklin  [47]  and  Jung  [77]  who
investigated  pHEMA-based  materials  only.  Franklin
incubated FDA groups I, II, and III in an artificial tear solution
containing various proteins and lipids. Lenses were manually
rubbed with various single and multipurpose solutions, and
the  protein  content  was  determined  using  fluorescence
spectroscopy. Franklin reported a protein reduction of 27–
45% for MPS care regimens [47], which is in close agreement
with  findings  from  Jung  et  al.  [77]  who  reported  protein
removal  efficiencies  of  28–52%  using  H2O2  and  MPS
regimens. In Jung’s in vitro study [77], which examined FDA
groups I–IV, proteins were extracted and quantified using a
protein assay. The results for FDA group IV lenses showed a
more efficient protein removal using H2O2 compared to the
polyhexamethylene biguanide-based MPS system, which is in
agreement to the results from our study using etafilcon A as
our FDA group IV lens.
The protein removal efficiency in our study, as evidenced
by the radiolabeled results, ranged from 2.9% to 62.4%, which
suggests that not only do care regimens impact the removal
efficiency but that this removal is also markedly influenced
by  the  specific  characteristics  of  the  lens  materials
investigated.
As described above two recent studies have shown that
rubbing lenses reduces visible deposition in both in vitro and
in  vivo  studies  [78,79].  In  our  study,  relatively  minor
differences  between  deposition  of  two  common  tear-film
proteins were demonstrated using an MPS system in a RUB
or NO-RUB format. Potential reasons why our in vitro study
was not able to mimic previous results is that this is the only
study to date to quantify protein removal from SH materials
by using RUB versus NO-RUB methods. The Nichols’ paper
[78] examined the removal of visible tear-film deposits from
a single SH material (galyfilcon A), which was not examined
in our study. The study by Cho and colleagues [79] examined
visible deposition, including albumin, but used an FDA group
IV material (ocufilcon D) that was also not examined in our
study. One potential issue to consider relative to patient use
of such systems is that our laboratory-based experiment used
nitrile-gloved hands for the RUB technique. Although the
gloves  had  textured  finger  tips  to  improve  grip,  potential
differences to ungloved hands may occur. Another limitation
of our in vitro experiment is that the lenses were incubated in
the  protein  solution  alone,  which  does  not  provide  the
intermittent surface drying that occurs between blinks in in
vivo studies and which may have impacted on the deposition
results. In reality, a follow-up ex vivo study in which lenses
are harvested and examined for deposited proteins from a
clinical study in which human subjects use an MPS in a RUB
and  then  NO-RUB  format  is  required  to  unequivocally
demonstrate differences between these formats. Although the
differences in protein removal between our two techniques
using MPS in a RUB and NO-RUB application are minor, it
must be considered that this may be entirely different for the
removal of lipids, microorganisms [88,89], and other debris.
The  use  of  lysozyme  and  albumin  in  single  protein
solutions describes the interaction between the protein and
material  of  interest;  however,  this  sorption  behavior  may
change with the addition of an artificial tear solution, which
includes  more  proteins,  lipids,  mucins,  and  ions.  A
competitive process of protein adsorption and desorption is
expected as smaller proteins get replaced by proteins with
higher surface affinity [43].
Biocompatible materials tend to bind proteins relatively
loosely, and these proteins are often easy to remove as they
maintain  their  conformation.  This  compares  with  “less
biocompatible”  surfaces,  which  are  typically  more
hydrophobic and have a tendency to denature proteins over
time, potentially stimulating inflammatory responses in the
biologic host [62,90-96]. Future work within the contact lens
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to surfaces compared to native proteins [3,55,62], which may
explain  our  difficulties  in  removing  either  protein  from
lotrafilcon B. Thus, our data suggest that when HEL deposits
on lotrafilcon B, it is difficult to remove, regardless of the care
regimen  employed.  In  comparison  BSA  sorbs  to  a  lesser
extent and is marginally easier to remove.
The balafilcon A material is surface modified using a
plasma oxidation method, which results in hydrophilic silicate
islands  distributed  over  the  lens  surface  [84].  This  study
showed  that  this  surface  modification  procedure  was  no
barrier for either protein as they both fully penetrated the
entire matrix (Figure 4A-D). In comparison to the increased
surface  build  up  of  both  proteins  seen  on  lotrafilcon  B,
balafilcon A accumulated slightly more HEL in the lens bulk
compared to the surface (Figure 4A,B) but showed an almost
even distribution for BSA (Figure 4C,D). The highly porous
and hydrophilic structure of balafilcon A [85-87] allowed easy
ingress of both proteins, particularly the smaller HEL, and
appeared to allow relatively easy removal of either protein
deposited, using any of the care regimens investigated, on both
the surface and from within the bulk region. Our quantitative
experiment  showed  the  highest  HEL  reductions  on  thisarena  should  focus  on  the  development  of  surfaces  that
maintain  protein  activity  and  allow  for  easier  removal  of
deposited  tear-film  components,  possibly  by  developing
contact lens care regimens and SH materials that are optimized
to work together.
In conclusion, the efficiency of protein removal varied
greatly between contact lens materials, care regimens, and
proteins  investigated.  MPS  in  a  RUB  and  NO-RUB
application and H2O2 removed significantly higher amounts
of HEL and BSA from etafilcon A and balafilcon A compared
Figure  4.  Lysozyme  and  albumin
distribution  through  balafilcon  A.
CLSM  (confocal  laser  scanning
microscopy)  scans  were  analyzed  to
locate  the  fluorescent-conjugated
protein on the front surface, within the
bulk region, and on the back surface of
balafilcon A after one and 14 days of
incubation. Lenses were either rinsed in
phosphate  buffered  saline  (PBS),
soaked overnight in hydrogen peroxide
(H2O2)  or  soaked  overnight  in  a
multipurpose  solution  (MPS)  with
(MPS-RUB)  or  without  (MPS-NO-
RUB) manual lens rubbing. A, B: These
panels show the results for HEL (hen
egg lysozyme), C, D: These panels show
the  results  for  BSA  (bovine  serum
albumin).
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TABLE 5. TOTAL AMOUNT OF HEN EGG LYSOZYME AND BOVINE SERUM ALBUMIN SORBED TO BALAFILCON A AFTER 1 AND 14 DAYS OF
        INCUBATION, FOLLOWED BY THE TREATMENTS RINSE, MPS-NO-RUB, MPS-RUB, OR H2O2 (MEAN±95% CONFIDENCE INTERVAL).
HEL BSA
BALAFILCON A
D1 D14
Difference
between
treatments*
D1 D14
Difference
between
treatments*
RINSE (a) 42.71±1.93 50.00±0.14 (b), (c), (d) 0.63±0.08 1.90±0.37 (b), (c), (d)
MPS-NO-RUB (b) 8.08±0.39 19.31±0.99 (a) 0.24±0.05 1.35±0.31 (a)
MPS-RUB (c) 7.69±0.71 20.80±3.30 (a) 0.20±0.04 1.32±0.30 (a)
H2O2 (d) 8.18±0.47 20.08±1.69 (a) 0.21±0.03 1.30±0.31 (a)
*Overall differences between treatments (p<0.05), using the combined time points.
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